(Worthy News) – The Food and Drug Administration (FDA) on Thursday expanded access to the abortion pill mifepristone, allowing patients to obtain it by mail instead of requiring in-person visits with specific health care providers.
The FDA said its decision to permanently remove the “in-person dispensing requirement” would “reduce burden on patient access and the health care delivery system.”
Through this action, patients can receive a prescription for mifepristone after a telemedicine appointment and have the pills sent directly to them. [ Source: The Hill (Read More…) ]
10
people are currently praying.
💡 Did you know? One of the best ways you can support
Worthy News is by simply
leaving a comment and sharing this article.
📢 Social media algorithms push content further when there’s more engagement —
so every 👍 like, 💬 comment, and 🔄 share helps more people discover the truth. 🙌
Fair Use Notice:This site contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available in our efforts to advance understanding of environmental, political, human rights, economic, democracy, scientific, and social justice issues, etc. We believe this constitutes a 'fair use' of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107, the material on this site is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. For more information go to: http://www.law.cornell.edu/uscode/17/107.shtml. If you wish to use copyrighted material from this site for purposes of your own that go beyond 'fair use', you must obtain permission from the copyright owner.
(Worthy News) – The Food and Drug Administration (FDA) on Thursday expanded access to the abortion pill mifepristone, allowing patients to obtain it by mail instead of requiring in-person visits with specific health care providers.